Literature DB >> 12638519

Aberrant receptor-mediated Cushing's syndrome.

Xavier Bertagna1, Lionel Groussin, Jean-Pierre Luton, Jérôme Bertherat.   

Abstract

Multiple alterations of G-protein-coupled receptors and G-proteins regulating intracellular transduction signal have been described in endocrine tumours. In Cushing's syndrome, aberrant or 'illicit' expression of membrane receptors (mainly G-protein-coupled receptors) has been observed in adrenal adenomas and adrenocorticotropic hormone (ACTH)-independent macronodular bilateral adrenal hyperplasia. The best characterized example to date is the aberrant expression of the gastric inhibitory polypeptide receptor that causes 'food-dependent hypercortisolism'. Aberrant expression of the luteinizing hormone, 2-adrenergic, interleukin receptors have also been reported. The level of expression of the vasopressin V1a receptor correlates with the direct (ACTH-independent) cortisol response to vasopressin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12638519     DOI: 10.1159/000067832

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  3 in total

Review 1.  Long delay in diagnosis of a case with MEN1 due to concomitant presence of AIMAH with insulinoma: a case report and literature review.

Authors:  Vajihe Chavoshi; Seyed Saeed Tamehri Zadeh; Shayesteh Khalili; Amirhassan Rabbani; Seyed Amir Hassan Matini; Zhaleh Mohsenifar; Farzad Hadaegh
Journal:  BMC Endocr Disord       Date:  2022-04-21       Impact factor: 3.263

2.  Diagnosis and treatment of adrenocorticotrophic hormone-independent macronodular adrenocortical hyperplasia: A report of 23 cases in a single center.

Authors:  Jiang Li; Chang-Hai Yang
Journal:  Exp Ther Med       Date:  2014-12-08       Impact factor: 2.447

3.  ARMC5 Primary Bilateral Macronodular Adrenal Hyperplasia Associated with a Meningioma: A Family Report.

Authors:  M J Ferreira; J Pedro; D Salazar; C Costa; J Aragão Rodrigues; M M Costa; A Grangeia; J L Castedo; D Carvalho
Journal:  Case Rep Endocrinol       Date:  2020-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.